Skip to main content

Vascular Access Management in Transcatheter Aortic Valve Implantation

  • Chapter
  • First Online:
Percutaneous Treatment of Left Side Cardiac Valves

Abstract

Though transcatheter aortic valve implantation (TAVI) has given ample proof of being a safe procedure, it is not devoid of complications. Peripheral vascular complications and bleeding at the access site are still among the problems most frequently associated with transfemoral TAVI. The transfemoral route is the access of first choice, and the improvement of TAVI devices has made it possible to reduce the size of introducers and delivery systems from the initial 22–24 Fr of the early devices to 18 Fr, first, and now to the 14–16 Fr of many new-generation devices. This has made it possible to broaden the range of indications treated with the transfemoral approach to serve a larger number of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Owen AR, Roditi GH. Peripheral arterial disease: the evolving role of non-invasive imaging. Postgrad Med J. 2011;87:189–98.

    Article  CAS  PubMed  Google Scholar 

  2. Zemedkun M, LaBounty TM, Bergman G, Wong SC, Lin FY, Reynolds D, Gomez M, Dunning AM, Leipsic J, Min JK. Effectiveness of a low contrast load CT angiography protocol in octogenarians and nonagenarians being evaluated for transcatheter aortic valve replacement. Clin Imaging. 2015;39(5):815–9.

    Article  PubMed  Google Scholar 

  3. Toggweiler S, Gurvitch R, Leipsic J, Wood DA, Willson AB, Binder RK, Cheung A, Ye J, Webb JG. Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure. J Am Coll Cardiol. 2012;59:113.

    Google Scholar 

  4. Arthurs ZM, Bishop PD, Feiten LE, Eagleton MJ, Clair DG, Kashyap VS. Evaluation of peripheral atherosclerosis: a comparative analysis of angiography and intravascular ultrasound imaging. J Vasc Surg. 2010;51:933–8.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Collins R, Burch J, Cranny G, Aguiar-Ibáñez R, Craig D, Wright K, Berry E, Gough M, Kleijnen J, Westwood M. Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review. BMJ. 2007;334:1257.

    Google Scholar 

  6. Webb JG, Altwegg L, Boone RH, Cheung A, Ye J, Lichtenstein S, Lee M, Masson JB, Thompson C, Moss R, Carere R, Munt B, Nietlispach F, Humphries K. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation. 2009;119:3009–16.

    Google Scholar 

  7. Toggweiler S, Webb J. Challenges in transcatheter aortic valve implantation. Swiss Med Wkly. 2012;142:w13735.

    PubMed  Google Scholar 

  8. Barbash IM, Barbanti M, Webb J, Molina-Martin De Nicolas J, Abramowitz Y, Latib A, Nguyen C, Deuschl F, Segev A, Sideris K, Buccheri S, Simonato M, Rosa FD, Tamburino C, Jilaihawi H, Miyazaki T, Himbert D, Schofer N, Guetta V, Bleiziffer S, Tchetche D, Immè S, Makkar RR, Vahanian A, Treede H, Lange R, Colombo A, Dvir D. Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation. Eur Heart J. 2015;36:3370–9.

    Google Scholar 

  9. Barbanti M, Binder RK, Freeman M, Wood DA, Leipsic J, Cheung A, Ye J, Tan J, Toggweiler S, Yang TH, Dvir D, Maryniak K, Lauck S, Webb JG. Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement. EuroIntervention. 2013;9:929–35.

    Google Scholar 

  10. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol. 2007;50:69–76.

    Article  PubMed  Google Scholar 

  11. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys PW. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention. 2008;4:242–9.

    Article  PubMed  Google Scholar 

  12. Thomas M, Schymik G, Walther T, Himbert D, Lefevre T, Treede H, Eggebrecht H, Rubino P, Colombo A, Lange R, Schwarz RR, Wendler O. One-year outcomes of cohort 1 in the edwards SAPIEN aortic bioprosthesis European outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2011;124:425–33.

    Article  PubMed  Google Scholar 

  13. Petronio AS, De Carlo M, Bedogni F, Maisano F, Ettori F, Klugmann S, Poli A, Marzocchi A, Santoro G, Napodano M, Ussia GP, Giannini C, Brambilla N, Colombo A. 2-year results of CoreValve implantation through the subclavian access: a propensity-matched comparison with the femoral access. J Am Coll Cardiol. 2012;60:502–7.

    Article  PubMed  Google Scholar 

  14. Muensterer A, Mazzitelli D, Ruge H, Wagner A, Hettich I, Piazza N, Lange R, Bleiziffer S. Safety and efficacy of the subcla- vian access route for TAVI in cases of missing transfemoral access. Clin Res Cardiol. 2013;102(9):627–36.

    Article  PubMed  Google Scholar 

  15. Modine T, Sudre A, Collet F, Delhaye C, Lemesles G, Fayad G, Koussa M. Transcutaneous aortic valve implantation using the axillary/subclavian access with patent left internal tho- racic artery to left anterior descending artery: feasibility and early clinical outcomes. J Thorac Cardiovasc Surg. 2012;144:1416–20.

    Article  PubMed  Google Scholar 

  16. Kliger C, Jelnin V, Sharma S, Panagopoulos G, Einhorn BN, Kumar R, Cuesta F, Maranan L, Kronzon I, Carelsen B, Cohen H, Perk G, Van Den Boomen R, Sahyoun C, Ruiz CE. CT angiography-fluoroscopy fusion imaging for percutaneous transapical access. JACC Cardiovasc Imaging. 2014;7:169–77.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marco Barbanti .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Barbanti, M., Pilato, G., Sgroi, C. (2018). Vascular Access Management in Transcatheter Aortic Valve Implantation. In: Tamburino, C., Barbanti, M., Capodanno, D. (eds) Percutaneous Treatment of Left Side Cardiac Valves. Springer, Cham. https://doi.org/10.1007/978-3-319-59620-4_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-59620-4_18

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-59619-8

  • Online ISBN: 978-3-319-59620-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics